New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 6, 2014
07:41 EDTFLDMFluidigm price target lowered to $52 from $65 at Maxim
Maxim lowered its price target for Fluidigm shares to $52 saying the company's Proteomics business pipeline is expected to take longer to convert than previously anticipated. The firm reiterates a Buy rating on the stock, however, saying the company's Q1 results were strong.
News For FLDM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 18, 2015
06:38 EDTFLDMFluidigm shares offer attractive entry point, says Leerink
Leerink believes the current share of Fluidigm represents an attractive entry point ahead of the company's new product launches. The firm thinks Fluidigm is well positioned to benefit from the growth in single cell analysis. It keeps an Outperform rating on the name with a $45 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use